edaravone has been researched along with Hypertrophy, Left Ventricular in 2 studies
Hypertrophy, Left Ventricular: Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Edaravone treatment shifted the %FAC(initial)–%FAC(final) relationship downward (P < 0." | 5.35 | Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats. ( Imai, K; Kawamoto, T; Miyamoto, Y; Neishi, Y; Okura, H; Toyota, E; Yoshida, K, 2009) |
| "Edaravone treatment shifted the %FAC(initial)–%FAC(final) relationship downward (P < 0." | 1.35 | Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats. ( Imai, K; Kawamoto, T; Miyamoto, Y; Neishi, Y; Okura, H; Toyota, E; Yoshida, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyota, E | 1 |
| Miyamoto, Y | 1 |
| Imai, K | 1 |
| Neishi, Y | 1 |
| Kawamoto, T | 1 |
| Okura, H | 1 |
| Yoshida, K | 1 |
| Tsujimoto, I | 1 |
| Hikoso, S | 1 |
| Yamaguchi, O | 1 |
| Kashiwase, K | 1 |
| Nakai, A | 1 |
| Takeda, T | 1 |
| Watanabe, T | 1 |
| Taniike, M | 1 |
| Matsumura, Y | 1 |
| Nishida, K | 1 |
| Hori, M | 1 |
| Kogo, M | 1 |
| Otsu, K | 1 |
2 other studies available for edaravone and Hypertrophy, Left Ventricular
| Article | Year |
|---|---|
Development of cardiac dysfunction induced by repetitive transient myocardial ischemia is inhibited by edaravone in conscious rats.
Topics: Animals; Antipyrine; Consciousness; Disease Models, Animal; Edaravone; Free Radical Scavengers; Hype | 2009 |
The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy.
Topics: Animals; Antioxidants; Antipyrine; Edaravone; Enzyme Activation; Free Radical Scavengers; Hypertensi | 2005 |